Latest Cytogenetics Stories
ALBANY, N.Y., April 16, 2013 /PRNewswire-USNewswire/ -- Three physician scientists whose landmark research helped transform the treatment of cancer are the recipients of the prestigious Albany Medical Center Prize in Medicine and Biomedical Research, to be officially awarded May 17. The $500,000 award, given to those who have altered the course of medical research, is one of the largest prizes in medicine and science in the United States. This year, the prize will recognize...
Michael Harper for redOrbit.com – Your Universe Online Multiple studies have concluded high amounts of cholesterol can be damaging to your heart and can, in turn, lead to Alzheimer’s disease or stroke. Though this single fact has been well documented, the exact reason why high cholesterol affects the brain has been largely unclear for many years. Researchers from the Linda Crnic Institute for Down Syndrome and the University of Colorado School of Medicine have studied this link and...
TROY, Idaho, April 10, 2013 /PRNewswire/ -- In early January, Sabrina Moyer launched a Facebook page (https://www.facebook.com/pages/Special-Miracles-Down-Syndrome/573115916038944) inspired by her son Colton Ryder, who had been diagnosed with Down syndrome soon after his birth in September. The goal was to update family and friends about his growth and development. However, what started out as a personal website quickly turned into a vibrant journey of advocacy attracting thousands...
SAN JOSE, Calif., March 18, 2013 /PRNewswire/ -- Ariosa Diagnostics, maker of the non-invasive Harmony(TM) Prenatal Test for risk assessment of common genetic conditions, has announced the expansion of the Harmony Prenatal Test to include the option of Y-chromosome analysis, which can provide information on fetal sex and aneuploidy as early as 10 weeks gestation. (Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO) The new "Harmony with Y test" will offer patients and...
FREMONT, Calif., March 4, 2013 /PRNewswire/ -- After a long and successful collaboration and partnership, BioGenex and Abbott Molecular have announced that BioGenex will take over direct sales and support responsibility for co-branded Xmatrx instruments, auto FISH reagents and consumables, with immediate effect. Xmatrx FISH, the product of successful partnership, enabled walk-away automation of all assay steps required to perform Abbott's FISH tests from baking to final cover slip,...
ABBOTT PARK, Ill., Feb. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will collaborate with Janssen Biotech, Inc. and Pharmacyclics, Inc. to explore the benefits of Abbott's proprietary FISH (fluorescence in situ hybridization) technology for use in developing a molecular companion diagnostic test to identify patients with a genetic subtype of chronic lymphocytic leukemia (CLL), the most common form of adult leukemia. Under the agreement, Abbott will develop a...
SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, announced today that the MaterniT21(TM) PLUS laboratory-developed test (LDT) available exclusively through Sequenom Center for Molecular Medicine (Sequenom CMM) will now report as additional findings the presence of certain fetal sex chromosomal aneuploidies, in addition to its identification of autosomal aneuploidies...
REDWOOD CITY, Calif., Jan. 10, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its proprietary prenatal technology can detect fetal subchromosomal abnormalities non-invasively from maternal blood. These proof-of-concept data show that Verinata's proprietary approach together with deep massively parallel sequencing (MPS) is able to produce a non-invasive fetal karyotype equivalent to that provided by...
Pensoft Publishers The study of chromosome changes arisen during species evolution is a current and intriguing topic that evolutionary biology proposes. However, in several groups (for example, mollusks), and chitons in particular, chromosome studies are scarce, with a few species investigated and analyses performed mostly with simple methods. Only 2,5% of about 900 living species of chitons have been so far karyologically investigated, all of them in the same order (Chitonida). The...
Lawrence LeBlond for redOrbit.com - Your Universe Online Two new papers published in the New England Journal of Medicine (NEJM) show that genetic testing in early pregnancy reveals far more about potential birth defects and stillbirth risk than current prenatal testing does, based on a multi-center clinical trial using both methods. The clinical trials showed that 6 percent of certain fetuses declared normal by conventional prenatal tests were found to have genetic abnormalities using...
